Your browser doesn't support javascript.
loading
Human beta-defensin 3 has immunosuppressive activity in vitro and in vivo.
Semple, Fiona; Webb, Sheila; Li, Hsin-Ni; Patel, Hetal B; Perretti, Mauro; Jackson, Ian J; Gray, Mohini; Davidson, Donald J; Dorin, Julia R.
Afiliação
  • Semple F; MRC Human Genetics Unit, Western General Hospital, Institute of Genetics and Molecular Medicine, Edinburgh, Scotland, UK. fsemple@hgu.mrc.ac.uk
Eur J Immunol ; 40(4): 1073-8, 2010 Apr.
Article em En | MEDLINE | ID: mdl-20104491
ABSTRACT
Beta-defensins are antimicrobial peptides with an essential role in the innate immune response. In addition beta-defensins can also chemoattract cells involved in adaptive immunity. Until now, based on evidence from dendritic cell stimulation, human beta defensin-3 (hBD3) was considered pro-inflammatory. We present evidence here that hBD3 lacks pro-inflammatory activity in human and mouse primary Mphi. In addition, in the presence of LPS, hBD3 and the murine orthologue Defb14 (but not hBD2), effectively inhibit TNF-alpha and IL-6 accumulation implying an anti-inflammatory function. hBD3 also inhibits CD40/IFN-gamma stimulation of Mphi and in vivo, hBD3 significantly reduces the LPS-induced TNF-alpha level in serum. Recent work has revealed that hBD3 binds melanocortin receptors but we provide evidence that these are not involved in hBD3 immunomodulatory activity. This implies a dual role for hBD3 in antimicrobial activity and resolution of inflammation.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Beta-Defensinas / Tolerância Imunológica / Inflamação Limite: Animals / Humans / Male Idioma: En Revista: Eur J Immunol Ano de publicação: 2010 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Beta-Defensinas / Tolerância Imunológica / Inflamação Limite: Animals / Humans / Male Idioma: En Revista: Eur J Immunol Ano de publicação: 2010 Tipo de documento: Article País de afiliação: Reino Unido